Abstract
To synthesize a water-soluble paclitaxel derivative, the anomers of diols of allyl 2,3,4-tri-O-benzyl-6-O-tritylglycoside (maltoside) were prepared, which can be separated by chromatographic procedure. One anomer was converted into α-glycosyloxyacetic acid (maltosyloxyacetic acid) by oxidative cleavage of the diol and subsequent oxidation. Ester-linked paclitaxel-glycoside conjugate, 7-glycolylpaclitaxel 2″-O-α-maltoside, was provided by condensation of 2′-TES paclitaxel with α-glycosyloxyacetic acid (maltosyloxyacetic acid) followed by deprotection of hydroxy groups.
Paclitaxel is one of the most important anticancer agents used in the treatment of breast and ovarian cancers. 1 It presents disadvantages such as low water solubility and toxicity toward normal tissues. To date many efforts have been made to modify paclitaxel chemically in order to create a more soluble and more easily delivered drug. 2 Paclitaxel prodrugs, that incorporate acids, have attracted much attention, because an ester linkage improves the solubility of paclitaxel and can be hydrolyzed by hydrolytic enzymes to release paclitaxel. 3
Glycosylation of bioactive compounds has been the subject of increasing attention, since it can enhance their water solubility, physicochemical stability, intestinal absorption, and biological half-life, and improve their bio- and pharmacological properties.4-6 So far, little attention has been paid to the synthesis of ester-linked paclitaxel-glycoside conjugates as water-soluble paclitaxel prodrugs, which employ enzymatic cleavage by hydrolytic enzymes including esterases and glycosidases as their mode of activation. On the other hand, convenient drug delivery system (DDS) using liposomes and bionanocapsules has attracted pharmacological attention. 7 However, the DDS system is not effective for delivering paclitaxel, because the present nano-particles can incorporate only soluble drugs.
On continuing the study to develop the technology for delivering paclitaxel, we investigated the synthesis of ester-linked paclitaxel-sugar conjugate, that is, 7-glycolylpaclitaxel 2″-O-α-maltoside.
The ester-linked paclitaxel-sugar conjugate, 7-glycolylpaclitaxel 2″-O-α-maltoside, was totally synthesized by chemical procedures. Allyl alcohol was linked to maltose by ether binding using triallyl orthoformate and acetyl chloride to give the product
The hydroxy group of paclitaxel was regioselectively triethylsilated by chlorotriethylsilane. After neutralization, dryness, concentration, and purification by column chromatography, 2′-TES ester of paclitaxel was prepared successfully. The condensation of 2′-TES ester of paclitaxel with carboxymethyl-2,3,4-tri-O-benzyl-6-O-tritylmaltoside (

Synthesis of 7-glycolylpaclitaxel 2″-O-α-maltosicde. (a) HC(OCH2CH = CH2)3/allyl alcohol (10 eq)/AcCl (1.2 eq), 50 °C, 24 h; (b) Ph3CCl (1.1 eq)/Py/DMAP (0.05 eq), rt, 24 h; (c) BnBr/NaH/dibenzo-18-crown-6/DMF/THF, rt, 12 h; (d) OsO4/50% NMO/dioxane, rt, 24 h, quant.; (e) NaIO4/dioxane, rt, 12 h; (f) NaClO2/t-BuOH/dioxane, rt, 3 h, quant.; (g) EDCI/DMAP/CH2Cl2, rt, 12 h, quant.; (h) H2/Pd black, rt, 24 h, quant.
Thus, paclitaxel (water solubility, ca. 0.4 μg/mL) was converted into hydrophilic paclitaxel derivative, that is, 7-glycolylpaclitaxel 2″-O-α-maltoside, which was much more water soluble than paclitaxel, by organic synthetic procedures. In this study, we investigated the convenient methods using diols of allyl 2,3,4-tri-O-benzyl-6-O-tritylmaltoside, which can be separated by column chromatography. Further studies on the DDS using the paclitaxel derivative, 7-glycolylpaclitaxel 2′′-O-α-maltoside, are now in progress in our laboratory.
Experimental
General
In the synthesis of ester-linked paclitaxel-glycoside conjugate, 7-glycolylpaclitaxel 2″-O-α-maltoside, commercially available chemical reagents such as paclitaxel were used. The nuclear magnetic resonance (NMR) spectra were recorded in CD3OD.
Synthesis of 7-Glycolylpaclitaxel 2″-O-α-Maltoside
To a mixture of triallyl orthoformate and acetyl chloride in allyl alcohol was added maltose. The mixture was stirred at 50 °C for a day. The mixture was neutralized by addition of pyridine, and the solvent was removed by evaporation. The condensed product
To a solution of paclitaxel and imidazole in DMF was added chlorotriethylsilane dropwise at room temperature. The mixture was stirred at room temperature for 2 h and diluted with ethyl acetate. The mixture was washed with water and brine, dried over magnesium sulfate, and concentrated in vacuo. Column chromatography of the residue on silica gel gave 2′-TES ester of paclitaxel. To a mixture of 2′-TES ester of paclitaxel in the presence of EDCI/DMAP in CH2Cl2 was added carboxymethyl-2,3,4-tri-O-benzyl-6-O-tritylmaltoside (
Product Identification
Spectral data of 7-glycolylpaclitaxel 2″-O-α-maltoside are as follows.
1H NMR (400 MHz, CD3OD, δ in ppm): δ 1.11 (s, H-16), 1.16 (s, H-17), 1.81 (s, H-19), 1.87 (m, H-6β), 2.00 (m, H-18, H-14α), 2.16 (s, CH3 in 10Ac), 2.21 (m, H-14β), 2.37 (s, CH3 in 4Ac), 2.58 (m, H-6α), 3.26 to 3.87 (m, H-2″, 2a, 2b, 3a, 3b, 4a, 4b, 5a, 5b, 6a, 6b), 3.88 (m, H-3), 4.20 (m, H-7, 20), 4.75 (d, J = 4.4 Hz, H-2′), 4.83 (m, H-1b), 5.00 (m, H-5), 5.16 (d, J = 2.8 Hz, H-1a), 5.64 (m, H-2, 3′), 6.15 (m, H-13), 6.21 (s, H-10), 7.29 (t, J = 3.8 Hz, p-H in Ph), 7.39 to 7.57 (m, m-H in NBz, p-H in NBz, m-H in OBz, o-H in Ph, m-H in Ph), 7.65 (m, p-H in OBz), 7.85 (d, J = 5.6 Hz, o-H in NBz), 8.10 (d, J = 6.0 Hz, o-H in OBz).
Footnotes
Declaration of Conflicting Interests
The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Funding
The authors received no financial support for the research, authorship, and/or publication of this article.
